ArticlePloS one2026

Performance of PREMM5, clinical criteria, and immunohistochemistry for MMR proteins in genetic risk assessment of Mexican patients with colorectal cancer.

José Luis Rodríguez-Olivares et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.